Pallymoney, United Kingdom

Victor Gault

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: University of Ulster, Other. Active years: 2021-2023.


% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Location History:

  • Pallymoney, GB (2021)
  • Ballymoney, GB (2023)

Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Victor Gault: Innovator in Diabetes and Bone Disorder Treatments

Introduction

Victor Gault is a notable inventor based in Pallymoney, GB. He has made significant contributions to the field of medical science, particularly in the treatment of diabetes and bone disorders. With a total of 2 patents, Gault's work has the potential to impact many lives.

Latest Patents

Gault's latest patents focus on polypeptides and analogues for use in the treatment of diabetes and bone disorders. The inventions relate to pharmaceutical compositions that comprise these polypeptides and analogues, along with methods for their application in treating these conditions. His innovative approach aims to provide new solutions for patients suffering from diabetes and related bone disorders.

Career Highlights

Throughout his career, Victor Gault has worked with esteemed institutions, including the University of Ulster. His research and inventions have garnered attention in the scientific community, showcasing his dedication to advancing medical treatments.

Collaborations

Gault has collaborated with various professionals in his field, including Nigel Irwin. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

Victor Gault's contributions to the treatment of diabetes and bone disorders through his patents highlight his role as a significant inventor in the medical field. His work continues to pave the way for advancements in healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…